Selected article for: "CV variation coefficient and variation coefficient"
Author: Guo, Jiao; Jia, Xiaoying; Liu, Yang; Wang, Shaobo; Cao, Junyuan; Zhang, Bo; Xiao, Gengfu; Wang, Wei
Title: Screening of Natural Extracts for Inhibitors against Japanese Encephalitis Virus Infection
  • Document date: 2020_2_21
    • ID: 161ck1i9_1
    Snippet: Optimization of HCS assay conditions. The HCS assay-optimized conditions contain cell density, infective dose, and assay endpoint. The assay conditions for HCS were optimized as follows: cell density of 10,000 cells per 96-well plate, a multiplicity of infection (MOI) of 0.8, and an endpoint of 24 h postinfection. The signal-to-basal (S/B) ratio, coefficient of variation (CV), and Z factor were 2,177, 8.9%, and 0.72, respectively, which demonstra.....
    Document: Optimization of HCS assay conditions. The HCS assay-optimized conditions contain cell density, infective dose, and assay endpoint. The assay conditions for HCS were optimized as follows: cell density of 10,000 cells per 96-well plate, a multiplicity of infection (MOI) of 0.8, and an endpoint of 24 h postinfection. The signal-to-basal (S/B) ratio, coefficient of variation (CV), and Z factor were 2,177, 8.9%, and 0.72, respectively, which demonstrated that the assay was robust and reproductive for the large-scale screening of novel antiviral compounds against JEV infection.

    Search related documents:
    Co phrase search for related documents
    • cell density and CV variation coefficient: 1, 2, 3
    • CV variation and infective dose: 1
    • CV variation and large scale: 1, 2
    • CV variation coefficient and infective dose: 1
    • CV variation coefficient and large scale: 1, 2
    • HCS assay and JEV infection: 1, 2
    • infection multiplicity and JEV infection: 1
    • infection multiplicity and large scale: 1
    • infection multiplicity and MOI infection multiplicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81
    • infective dose and large scale: 1
    • infective dose and MOI infection multiplicity: 1
    • JEV infection and MOI infection multiplicity: 1
    • large scale and MOI infection multiplicity: 1